One twenty-two protein (RBM15; OTT); megakaryocytic acute leukemia (MKL1; MAL); myeloproliferative leukemia virus oncogene (MPL); recombination signal binding protein for immunoglobulin κ J region (RBPJ) BriefCommunication Pages: 522 - 522
Hairy and enhancer of split1 (HES1); notch homolog 1 translocation-associated (Drosophila) (NOTCH1); tenascin-C (TNC) BriefCommunication Pages: 525 - 525
11β-Hydroxysteroid dehydrogenase type 2 (HSD11B2; 11β HSD2); cyclooxygenase-2 (PTGS2; COX-2) BriefCommunication Pages: 528 - 528
β-Catenin; jagged 1 (JAG1); notch homolog 1 translocation-associated (Drosophila) (NOTCH1); NOTCH2 BriefCommunication Pages: 529 - 529
Peroxisome proliferator–activated receptor-δ (PPARD; PPARB; PPARδ) BriefCommunication Pages: 534 - 534
DNA gyrase (type II topoisomerase), bacterial (gyrA); DNA topoisomerase IV, bacterial (parC) BriefCommunication Pages: 537 - 537
V-ets erythroblastosis virus E26 oncogene homolog 1 (avian) (ETS1) BriefCommunication Pages: 538 - 538
Matrix metallopeptidase 7 (matrilysin, uterine) (MMP7); IL-25; aldehyde dehydrogenase 1 family, member A1 (ALDH1A1; RALDH1A1) BriefCommunication Pages: 541 - 541
Interferon-γ (IFN-γ); tumor necrosis factor-α (TNF-α); vitamin D receptor (VDR) BriefCommunication Pages: 542 - 542
MicroRNA-106a (miRNA-106a); early growth response 1 (EGR1); specificity protein 1 transcription factor (SP1); IL-10 BriefCommunication Pages: 543 - 543
G protein–coupled receptor 109A (NIACR1; GPR109A; HM74A); cytochrome P450 family 2 subfamily C polypeptide 8 (CYP2C8); CYP2C9 BriefCommunication Pages: 544 - 544
c-jun N-terminal kinase (JNK); monocyte chemoattractant protein-1 (CCL2; MCP-1) BriefCommunication Pages: 548 - 548
Lipoxin A4 (LXA4); peroxisome proliferator–activated receptor-γ (PPARG; PPARγ) BriefCommunication Pages: 549 - 549
Cholinergic receptor, nicotinic, α3 (CHRNA3); CHRNA5; hedgehog interacting protein (HHIP) BriefCommunication Pages: 550 - 550
MicroRNA-142-5p (miRNA-142-5p); miRNA-155; miRNA-223; miRNA-10b; miRNA-30a-3p BriefCommunication Pages: 552 - 552
c-jun N-terminal kinase 3 (JNK3; MAPK10); stromal derived factor-1 (CXCL12; SDF-1) BriefCommunication Pages: 553 - 553
Identification of chemically feasible molecular fragments to aid in drug discovery BriefCommunication Pages: 554 - 554
Acetalated dextran (Ac-DEX) with tunable degradation rates for controlled particulate immunotherapy BriefCommunication Pages: 555 - 555
Targeted delivery of therapeutic small interfering RNA using cationic lipid–based nanoparticles BriefCommunication Pages: 556 - 556
Targeted, systemic delivery of therapeutic small interfering RNA nanoparticles BriefCommunication Pages: 557 - 557
Spinal cord stimulation for treating motor symptoms in Parkinson's disease (PD) BriefCommunication Pages: 560 - 560